Gene · 5818
Papers3,675
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,675
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unleashing the Antiviral Potential of Stapled Peptides: A New Frontier in Combating Human Neurotropic Viral Infections. | Microb Biotechnol | 2025 | 40955200 | PubTator, text mining | PubMed |
| Chimeric PRR T-cell-engager targeting cell surface β-1,3-glucan for invasive candidiasis. | PLoS Pathog | 2025 | 40953078 | PubTator, text mining | PubMed |
| HIV-1 manipulates CD96 on CD4+ T cells to subvert antiviral immunity. | Sci Adv | 2025 | 40911682 | PubTator, text mining | PubMed |
| MERS-CoV antagonizes PKR activation by inhibiting its condensation at viral replication complexes. | bioRxiv | 2025 | 40894672 | PubTator, text mining | PubMed |
| A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for Definity. | PLoS One | 2025 | 40880409 | PubTator, text mining | PubMed |
| Damage-associated molecular patterns (DAMPs) in diseases: implications for therapy. | Mol Biomed | 2025 | 40877572 | PubTator, text mining | PubMed |
| Study on differentially expressed genes and pattern recognition receptors in osteoporosis based on bioinformatics analysis. | Sci Rep | 2025 | 40854963 | PubTator, text mining | PubMed |
| Neurotropism of alphaherpesviruses is most prominent in the mesiotemporal, piriform and prefrontal cortices in mice. | Neuroscience | 2025 | 40850663 | PubTator, text mining | PubMed |
| Resistance to oncolytic virotherapy: Multidimensional mechanisms and therapeutic breakthroughs (Review). | Int J Mol Med | 2025 | 40849827 | PubTator, text mining | PubMed |
| Relationship between baseline platelet-to-red blood cell distribution width ratio and all-cause mortality in non-traumatic subarachnoid hemorrhage: A retrospective analysis of the MIMIC-IV database. | PLoS One | 2025 | 40845074 | PubTator, text mining | PubMed |
| Evaluating the association between migraine treatments and tinnitus: Insights from the US Food and Drug Administration adverse event reporting system. | PLoS One | 2025 | 40833961 | PubTator, text mining | PubMed |
| Anti-Herpes Simplex Virus Type 1 Activity of Rosa damascena Mill Essential Oil and Floral Water in Retinal Infection In Vitro and In Silico. | Int J Mol Sci | 2025 | 40806646 | PubTator, text mining | PubMed |
| Comprehensive view on chemotherapy-free management of acute myeloid leukemia by using venetoclax in combination with targeted and/or immune therapies. | Cell Death Discov | 2025 | 40804253 | PubTator, text mining | PubMed |
| Unraveling NK cell heterogeneity through single-cell sequencing: insights from physiological and tumor contexts for clinical applications. | Front Immunol | 2025 | 40761786 | PubTator, text mining | PubMed |
| Pattern recognition receptors: function, regulation and therapeutic potential. | Signal Transduct Target Ther | 2025 | 40640149 | PubTator, text mining | PubMed |
| Machine learning developed an immune evasion signature for predicting prognosis and immunotherapy benefits in lung adenocarcinoma. | Front Cell Dev Biol | 2025 | 40612112 | PubTator, text mining | PubMed |
| Nanocarrier-Based Targeting of Pattern Recognition Receptors as an Innovative Strategy for Enhancing Sepsis Therapy. | Adv Healthc Mater | 2025 | 40599085 | PubTator, text mining | PubMed |
| Collagen XXIII (COL23A1): A novel risk factor for eczema herpeticum. | J Allergy Clin Immunol | 2025 | 40562081 | PubTator, text mining | PubMed |
| Uncovering the Anti-Herpetic Activity of Anionic Peptides Derived From the Cytoplasmic Domain of Nectin-1. | Bioinform Biol Insights | 2025 | 40547845 | PubTator, text mining | PubMed |
| Nonlytic Egress and Transmission in the Virus World. | Annu Rev Biochem | 2025 | 40540754 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5818/papers?page=6